| Sandoz Pharmaceuticals AG - Pomalidomid Sandoz 3 mg, Hartkapseln | | 69131 | | 03 | | Pomalidomid Sandoz 3 mg | | Hartkapseln | | L04AX06 | | Pomalidomide | | 03.06.2024 | | |
| | Composition | | pomalidomidum 3 mg, cellulosum microcristallinum, maltodextrinum, natrii stearylis fumaras, Kapselhülle: gelatina, E 171, E 172 (flavum), E 172 (rubrum), E 132, Drucktinte: lacca, E 171, propylenglycolum, pro capsula corresp. natrium 0.021 mg. | | Packungsbestandteile | | Capsules | | | | | | | | Principe actif | Concentr. |
|---|
| Pomalidomidum | 3 mg |
| | BAG: Principe actif | Concentr. |
|---|
| Pomalidomidum | 3 mg |
| | | | Agents auxilliaires | | informations additionels |
|---|
| (Flavum) | | | | (Rubrum) | | | | Cellulosum Microcristallinum | | | | E 132 | | color. | | E 171 | | color. | | E 172 | | color. | | Gelatina | | Kapselhülle | | Lacca | | Drucktinte | | Maltodextrine | | | | Natrii Stearylis Fumaras | | | | Propylenglycol | | |
| |
| | numéro d'emballage | Taille des présentations | PEF | PP | Cat. | LS | Hors commerce (MedRef) |
|---|
| 005 | 14 | DDP | DDP | A | | Non | | 006 | 21 | 3207.21 | 3504.45 | A | LS | Non |
|
|
